Derivatives analysts recommend a Bullish 1:2 Call Ratio Spread on Aurobindo Pharma (550 lot size) for upcoming option cycles. By buying a ₹1,520 Call and selling two ₹1,580/₹1,600 Calls, traders minimize net premium costs while targeting optimal profits if the stock moves moderately higher toward ₹1,600.
MUMBAI, July 30, 2026 — Derivatives analysts across major domestic brokerages have highlighted a Bullish Call Ratio Spread strategy on pharmaceutical major Aurobindo Pharma Limited (NSE: AUROPHARMA) for the upcoming weekly and monthly derivatives cycles. The recommended option structure involves buying one In-The-Money (ITM) or At-The-Money (ATM) call option while simultaneously selling two Out-Of-The-Money (OTM) call options. Positioned as a low-cost, defined-risk strategy, the setup is designed to capture moderate upside potential in the stock while maintaining a strong margin of safety against unexpected range-bound consolidation or minor pullbacks in the pharmaceutical sector.
Technical Setup and Derivative Structure
Aurobindo Pharma shares have demonstrated steady accumulation on cash market charts, consolidating near key short-term exponential moving averages (EMAs). Open Interest (OI) concentration across options chains indicates substantial support build-up in the ₹1,500 to ₹1,520 range, with call writers active across higher strike clusters between ₹1,580 and ₹1,620.
Under the Call Ratio Spread framework, a trader buys one lot of an lower call strike (such as the ₹1,520 Call) and writes two lots of a higher call strike (such as the ₹1,580 or ₹1,600 Call). The net premium received from selling the two OTM calls substantially offsets or entirely covers the premium paid for the lower strike call, creating a low-net-debit or net-credit position.
| Options Leg | Strike Price | Lot Size | Delta / Position | Strategic Objective |
| Leg 1: Buy Call (ITM/ATM) | ₹1,520 Strike | 550 Shares | Long 1 Lot | Captures primary upside price movement |
| Leg 2: Sell Call (OTM) | ₹1,580 / ₹1,600 Strike | 550 Shares (x2) | Short 2 Lots | Reduces net entry cost & funds long leg |
| Net Strategy Profile | Spread Setup | 550 Shares/Lot | Defined Maximum Gain | Max profit achieved at higher strike |
Payoff Mechanics, Risk, and Return Profile
The Call Ratio Spread strategy optimizes returns when the underlying stock trends moderately higher toward the short call strike price by contract expiry. The maximum profitability for the position occurs if Aurobindo Pharma settles exactly at the short call strike (e.g., ₹1,580–₹1,600) at expiration. At this peak payoff point, the long call generates full intrinsic value while both short calls expire worthless, maximizing net spread gains.
Because the structure involves writing an extra uncovered option leg, derivative desks advise traders to strictly monitor upside breakeven levels. If the stock surges past the higher strike plus the maximum profit margin, the uncovered short call creates unlimited upside risk. To mitigate this, risk managers recommend implementing a strict stop-loss on the underlying cash stock price if it breaks key technical resistance levels above ₹1,620 with high volume.
Official Sources Section
According to official derivative market updates published by the National Stock Exchange of India and trading data logged on the BSE Limited, options contracts for Aurobindo Pharma trade in standardized lot sizes of 550 shares. Market participants operate under clearing guidelines mandated by the Securities and Exchange Board of India (SEBI).
Quote Section
"According to officials and derivative analysts at leading brokerage desks, ratio spreads offer an effective risk-reward profile for stocks exhibiting steady, incremental momentum without the high premium decay risks associated with outright long option purchases."
Why It Matters
Derivative strategies like the Call Ratio Spread allow retail traders and institutional investors to participate in positive equity momentum while managing options time-decay (Theta) and high implied volatility (IV). For active market participants in the F&O segment, utilizing defined-ratio spreads provides structured capital efficiency and risk control during earnings seasons and broader sectoral rotations.
Key Facts at a Glance
Strategy Type: Bullish 1:2 Call Ratio Spread on Aurobindo Pharma Limited.
Contract Lot Size: 550 shares per derivative lot on the NSE.
Core Execution: Buy 1 lower strike call (₹1,520) and sell 2 higher strike calls (₹1,580/₹1,600).
Optimal Outcome: Maximum gain achieved if the stock price moves toward ₹1,580–₹1,600 by expiry.
Risk Management: Requires strict stop-loss rules due to potential risk if the stock surges well beyond the upper breakeven point.
Frequently Asked Questions (FAQs)
What is a Call Ratio Spread in options trading?
A Call Ratio Spread is a multi-leg options strategy that involves buying a specific number of call options at a lower strike price and selling a larger number of call options at a higher strike price of the same underlying asset and expiration date.
What is the primary benefit of using a Call Ratio Spread on Aurobindo Pharma?
The primary benefit is reducing or eliminating the entry cost (net premium paid) of the trade, allowing the trader to profit from a moderate upward price movement while minimizing losses if the stock remains stagnant or drops.
What is the lot size for Aurobindo Pharma F&O contracts?
The market lot size for Aurobindo Pharma derivatives on the National Stock Exchange of India (NSE) is 550 shares.
Where can derivative traders track live options data for Aurobindo Pharma?
Real-time open interest charts, options chain data, and trade volumes can be monitored on the official web portals of the National Stock Exchange of India and the BSE Limited.
Source: National Stock Exchange of India, BSE Limited, Securities and Exchange Board of India (SEBI)